bioRxiv Science⌕ Search

Biology subjects

Zeng, J.

Publications and source records attributed to Zeng, J..

174 records · Page 10Linked to original sources

HPCDb: an integrated database of pancreatic cancer

We have established a database of Human Pancreatic Cancer (HPCDb) through effectively mining, extracting, analyzing, and integrating PC-related genes, single-nucleotide polymorphisms (SNPs), and microRNAs (miRNAs), now available online at http://www.pancancer.org/. Data were extracted from established databases, [≥]5 published literature (PubMed), and microarray chips (screening of differentially expressed genes using limma package in R, |log2 fold change (FC)| > 1). Further, protein-protein interactions (PPIs) were investigated through the Human Protein Reference Database. miRNA-target relationships were also identified using the online software TargetScan. Currently, HPCDb contains 3284 genes, 120 miRNAs, 589 SNPs, 10,139 PPIs, and 3904 miRNA-target pairs. The detailed information on PC-related genes (e.g., gene identifier (ID), symbol, synonyms, full name, chip sets, expression alteration, PubMed ID, and PPIs), miRNAs (e.g., accession number, chromosome location, related disease, PubMed ID, and miRNA-target interactions), and SNPs (e.g., SNP ID, allele, gene, PubMed ID, chromosome location, and disease) is presented through user-friendly query interfaces or convenient links to NCBI GEO, NCBI PubMed, NCBI Gene, NCBI dbSNP, and miRBase. Overall, HPCDb provides biologists with relevant information on human PC-related molecules at multiple levels, helping to generate new hypotheses or identify candidate markers.

bioinformatics↗

A Synthetic Microbial Operational Amplifier

Synthetic biology has created oscillators, latches, logic gates, logarithmically linear circuits, and load drivers that have electronic analogs in living cells. The ubiquitous operational amplifier, which allows circuits to operate robustly and precisely has not been built with bio-molecular parts. As in electronics, a biological operational-amplifier could greatly improve the predictability of circuits despite noise and variability, a problem that all cellular circuits face. Here, we show how to create a synthetic 3-stage inducer-input operational amplifier with a differential transcription-factor stage, a CRISPR-based push-pull stage, and an enzymatic output stage with just 5 proteins including dCas9. Our Bio-OpAmp expands the toolkit of fundamental circuits available to bioengineers or biologists, and may shed insight into biological systems that require robust and precise molecular homeostasis and regulation.\n\nOne Sentence SummaryA synthetic bio-molecular operational amplifier that can enable robust, precise, and programmable homeostasis and regulation in living cells with just 5 protein parts is described.

synthetic biology↗

GEM: A manifold learning based framework for reconstructing spatial organizations of chromosomes

Decoding the spatial organizations of chromosomes has crucial implications for studying eukaryotic gene regulation. Recently, Chromosomal conformation capture based technologies, such as Hi-C, have been widely used to uncover the interaction frequencies of genomic loci in high-throughput and genome-wide manner and provide new insights into the folding of three-dimensional (3D) genome structure. In this paper, we develop a novel manifold learning framework, called GEM (Genomic organization reconstructor based on conformational Energy and Manifold learning), to elucidate the underlying 3D spatial organizations of chromosomes from Hi-C data. Unlike previous chromatin structure reconstruction methods, which explicitly assume specific relationships between Hi-C interaction frequencies and spatial distances between distal genomic loci, GEM is able to reconstruct an ensemble of chromatin conformations by directly embedding the neigh-boring affinities from Hi-C space into 3D Euclidean space based on a manifold learning strategy that considers both the fitness of Hi-C data and the biophysical feasibility of the modeled structures, which are measured by the conformational energy derived from our current biophysical knowledge about the 3D polymer model. Extensive validation tests on both simulated interaction frequency data and experimental Hi-C data of yeast and human demonstrated that GEM not only greatly outperformed other state-of-art modeling methods but also reconstructed accurate chromatin structures that agreed well with the hold-out or independent Hi-C data and sparse geometric restraints derived from the previous fluorescence in situ hybridization (FISH) studies. In addition, as GEM can generate accurate spatial organizations of chromosomes by integrating both experimentally-derived spatial contacts and conformational energy, we for the first time extended our modeling method to recover long-range genomic interactions that are missing from the original Hi-C data. All these results indicated that GEM can provide a physically and physiologically valid 3D representations of the organizations of chromosomes and thus serve as an effective and useful genome structure reconstructor.

bioinformatics↗

Widespread signatures of negative selection in the genetic architecture of human complex traits

Estimation of the joint distribution of effect size and minor allele frequency (MAF) for genetic variants is important for understanding the genetic basis of complex trait variation and can be used to detect signature of natural selection. We develop a Bayesian mixed linear model that simultaneously estimates SNP-based heritability, polygenicity (i.e. the proportion of SNPs with nonzero effects) and the relationship between effect size and MAF for complex traits in conventionally unrelated individuals using genome-wide SNP data. We apply the method to 28 complex traits in the UK Biobank data (N = 126,752), and show that on average across 28 traits, 6% of SNPs have nonzero effects, which in total explain 22% of phenotypic variance. We detect significant (p < 0.05/28 =1.8x10-3) signatures of natural selection for 23 out of 28 traits including reproductive, cardiovascular, and anthropometric traits, as well as educational attainment. We further apply the method to 27,869 gene expression traits (N = 1,748), and identify 30 genes that show significant (p < 2.3x10-6) evidence of natural selection. All the significant estimates of the relationship between effect size and MAF in either complex traits or gene expression traits are consistent with a model of negative selection, as confirmed by forward simulation. We conclude that natural selection acts pervasively on human complex traits shaping genetic variation in the form of negative selection.

genetics↗

Phosphate Is The Third Nutrient Monitored By TOR In Candida albicans And Provides A Target For Fungal-Specific Indirect TOR Inhibition

The TOR pathway regulates morphogenesis and responses to host cells in the fungal pathogen Candida albicans. Eukaryotic TOR complex 1 (TORC1) induces growth and proliferation in response to nitrogen and carbon source availability. Our unbiased genetic approach seeking new components of TORC1 signaling in C. albicans revealed that the phosphate transporter Pho84 is required for normal TORC1 activity. We found that mutants in PHO84 are hypersensitive to rapamycin and, in response to phosphate feeding, generate less phosphorylated ribosomal protein S6 (P-S6) than wild type. The small GTPase Gtr1, a component of the TORC1-activating EGO complex, links Pho84 to TORC1. Mutants in Gtr1, but not in another TORC1-activating GTPase, Rhb1, are defective in the P-S6 response to phosphate. Overexpression of Gtr1 and of a constitutively active Gtr1Q67L mutant suppress TORC1-related defects. In S. cerevisiae pho84 mutants, constitutively active Gtr1 suppresses a TORC1 signaling defect but does not rescue rapamycin hypersensitivity. Hence connections from phosphate homeostasis to TORC1 may differ between C. albicans and S. cerevisiae. The converse direction of signaling, from TORC1 to the phosphate homeostasis (PHO) regulon, previously observed in S. cerevisiae, was genetically demonstrated in C. albicans using conditional TOR1 alleles. A small molecule inhibitor of Pho84, an FDA-approved drug, inhibits TORC1 signaling and potentiates the activity of the antifungals amphotericin B and micafungin. Anabolic TORC1-dependent processes require significant amounts of phosphate. Our study demonstrates that phosphate availability is monitored and also controlled by TORC1, and that TORC1 can be indirectly targeted by inhibiting Pho84.\n\nSignificanceThe human fungal pathogen Candida albicans uses the TOR signaling pathway to contend with varying host environments and thereby regulate cell growth. Seeking novel components of the C. albicans TOR pathway we identified a cell-surface phosphate importer, Pho84, and its molecular link to TOR complex 1 (TORC1). Since phosphorus is a critical element for anabolic processes like DNA replication, ribosome biogenesis, translation and membrane biosynthesis, TORC1 monitors its availability in regulating these processes. By depleting the central kinase in the TORC1 pathway, we showed that TORC1 signaling modulates regulation of phosphate acquisition. An FDA-approved small-molecule inhibitor of Pho84 inhibits TORC1 signaling and potentiates the activity of the gold-standard antifungal amphotericin B and the echinocandin micafungin.

microbiology↗

Metagenomic binning through low density hashing

Bacterial microbiomes of incredible complexity are found throughout the world, from exotic marine locations to the soil in our yards to within our very guts. With recent advances in Next-Generation Sequencing (NGS) technologies, we have vastly greater quantities of microbial genome data, but the nature of environmental samples is such that DNA from different species are mixed together. Here, we present Opal for metagenomic binning, the task of identifying the origin species of DNA sequencing reads. Our Opal method introduces low-density, even-coverage hashing to bioinformatics applications, enabling quick and accurate metagenomic binning. Our tool is up to two orders of magnitude faster than leading alignment-based methods at similar or improved accuracy, allowing computational tractability on large metagenomic datasets. Moreover, on public benchmarks, Opal is substantially more accurate than both alignment-based and alignment-free methods (e.g. on SimHC20.500, Opal achieves 95% F1-score while Kraken and CLARK achieve just 91% and 88%, respectively); this improvement is likely due to the fact that the latter methods cannot handle computationally-costly long-range dependencies, which our even-coverage, low-density fingerprints resolve. Notably, capturing these long-range dependencies drastically improves Opals ability to detect unknown species that share a genus or phylum with known bacteria. Additionally, the family of hash functions Opal uses can be generalized to other sequence analysis tasks that rely on k-mer based methods to encode long-range dependencies.

bioinformatics↗

Characterizing RNA Pseudouridylation By Convolutional Neural Networks

The most prevalent post-transcriptional RNA modification, pseudouridine ({Psi}), also known as the fifth ribonucleoside, is widespread in rRNAs, tRNAs, snRNAs, snoRNAs and mRNAs. Pseudouridines in RNAs are implicated in many aspects of post-transcriptional regulation, such as the maintenance of translation fidelity, control of RNA stability and stabilization of RNA structure. However, our understanding of the functions, mechanisms as well as precise distribution of pseudourdines (especially in mRNAs) still remains largely unclear. Though thousands of RNA pseudouridylation sites have been identified by high-throughput experimental techniques recently, the landscape of pseudouridines across the whole transcriptome has not yet been fully delineated. In this study, we present a highly effective model, called PULSE (PseudoUridyLation Sites Estimator), to predict novel {Psi} sites from large-scale profiling data of pseudouridines and characterize the contextual sequence features of pseudouridylation. PULSE employs a deep learning framework, called convolutional neural network (CNN), which has been successfully and widely used for sequence pattern discovery in the literature. Our extensive validation tests demonstrated that PULSE can outperform conventional learning models and achieve high prediction accuracy, thus enabling us to further characterize the transcriptome-wide landscape of pseudouridine sites. Overall, PULSE can provide a useful tool to further investigate the functional roles of pseudouridylation in post-transcriptional regulation.

bioinformatics↗

TIDE: predicting translation initiation sites by deep learning

MotivationTranslation initiation is a key step in the regulation of gene expression. In addition to the annotated translation initiation sites (TISs), the translation process may also start at multiple alternative TISs (including both AUG and non-AUG codons), which makes it challenging to predict TISs and study the underlying regulatory mechanisms. Meanwhile, the advent of several high-throughput sequencing techniques for profiling initiating ribosomes at single-nucleotide resolution, e.g., GTI-seq and QTI-seq, provides abundant data for systematically studying the general principles of translation initiation and the development of computational method for TIS identification.\n\nMethodsWe have developed a deep learning based framework, named TITER, for accurately predicting TISs on a genome-wide scale based on QTI-seq data. TITER extracts the sequence features of translation initiation from the surrounding sequence contexts of TISs using a hybrid neural network and further integrates the prior preference of TIS codon composition into a unified prediction framework.\n\nResultsExtensive tests demonstrated that TITER can greatly outperform the state-of-the-art prediction methods in identifying TISs. In addition, TITER was able to identify important sequence signatures for individual types of TIS codons, including a Kozak-sequence-like motif for AUG start codon. Furthermore, the TITER prediction score can be related to the strength of translation initiation in various biological scenarios, including the repressive effect of the upstream open reading frames (uORFs) on gene expression and the mutational effects influencing translation initiation efficiency.\n\nAvailabilityTITER is available as an open-source software and can be downloaded from https://github.com/zhangsaithu/titer\n\nContactlzhang20@mail.tsinghua.edu.cn and zengjy321@tsinghua.edu.cn

bioinformatics↗

Multiple-trait Bayesian Regression Methods with Mixture Priors for Genomic Prediction

Bayesian multiple-regression methods incorporating different mixture priors for marker effects are widely used in genomic prediction. Improvement in prediction accuracies from using those methods, such as BayesB, BayesC and BayesC{pi}, have been shown in single-trait analyses with both simulated data and real data. These methods have been extended to multi-trait analyses, but only under a specific limited circumstance that assumes a locus affects all the traits or none of them. In this paper, we develop and implement the most general multi-trait BayesC{Pi} and BayesB methods allowing a broader range of mixture priors. Further, we compare them to single-trait methods and the \"restricted\" multi-trait formulation using real data. In those data analyses, significant higher prediction accuracies were sometimes observed from these new broad-based multi-trait Bayesian multiple-regression methods. The software tool JWAS offers routines to perform the analyses.

genetics↗

A Network Integration Approach for Drug-Target Interaction Prediction and Computational Drug Repositioning from Heterogeneous Information

The emergence of large-scale genomic, chemical and pharmacological data provides new opportunities for drug discovery and repositioning. Systematic integration of these heterogeneous data not only serves as a promising tool for identifying new drug-target interactions (DTIs), which is an important step in drug development, but also provides a more complete understanding of the molecular mechanisms of drug action. In this work, we integrate diverse drug-related information, including drugs, proteins, diseases and side-effects, together with their interactions, associations or similarities, to construct a heterogeneous network with 12,015 nodes and 1,895,445 edges. We then develop a new computational pipeline, called DTINet, to predict novel drug-target interactions from the constructed heterogeneous network. Specifically, DTINet focuses on learning a low-dimensional vector representation of features for each node, which accurately explains the topological properties of individual nodes in the heterogeneous network, and then predicts the likelihood of a new DTI based on these representations via a vector space projection scheme. DTINet achieves substantial performance improvement over other state-of-the-art methods for DTI prediction. Moreover, we have experimentally validated the novel interactions between three drugs and the cyclooxygenase (COX) protein family predicted by DTINet, and demonstrated the new potential applications of these identified COX inhibitors in preventing inflammatory diseases. These results indicate that DTINet can provide a practically useful tool for integrating heterogeneous information to predict new drug-target interactions and repurpose existing drugs. The source code of DTINet and the input heterogeneous network data can be downloaded from http://github.com/luoyunan/DTINet.

bioinformatics↗

A Deep Boosting Based Approach for Capturing the Sequence Binding Preferences of RNA-Binding Proteins from High-Throughput CLIP-Seq Data

Characterizing the binding behaviors of RNA-binding proteins (RBPs) is important for understanding their functional roles in gene expression regulation. However, current high-throughput experimental methods for identifying RBP targets, such as CLIP-seq and RNAcompete, usually suffer from the false positive and false negative issues. Here, we develop a deep boosting based machine learning approach, called DeBooster, to accurately model the binding sequence preferences and identify the corresponding binding targets of RBPs from CLIP-seq data. Comprehensive validation tests have shown that DeBooster can outperform other state-of-the-art approaches in predicting RBP targets and recover false negatives that are common in current CLIP-seq data. In addition, we have demonstrated several new potential applications of DeBooster in understanding the regulatory functions of RBPs, including the binding effects of the RNA helicase MOV10 on mRNA degradation, the influence of different binding behaviors of the ADAR proteins on RNA editing, as well as the antagonizing effect of RBP binding on miRNA repression. Moreover, DeBooster may provide an effective index to investigate the effect of pathogenic mutations in RBP binding sites, especially those related to splicing events. We expect that DeBooster will be widely applied to analyze large-scale CLIP-seq experimental data and can provide a practically useful tool for novel biological discoveries in understanding the regulatory mechanisms of RBPs. The scource code of DeBooster can be downloaded from http://github.com/dongfanghong/deepboost.

bioinformatics↗

Deep learning with feature embedding for compound-proteininteraction prediction

Accurately identifying compound-protein interactions in silico can deepen our understanding of the mechanisms of drug action and significantly facilitate the drug discovery and development process. Traditional similarity-based computational models for compound-protein interaction prediction rarely exploit the latent features from current available large-scale unlabelled compound and protein data, and often limit their usage on relatively small-scale datasets. We propose a new scheme that combines feature embedding (a technique of representation learning) with deep learning for predicting compound-protein interactions. Our method automatically learns the low-dimensional implicit but expressive features for compounds and proteins from the massive amount of unlabelled data. Combining effective feature embedding with powerful deep learning techniques, our method provides a general computational pipeline for accurate compound-protein interaction prediction, even when the interaction knowledge of compounds and proteins is entirely unknown. Evaluations on current large-scale databases of the measured compound-protein affinities, such as ChEMBL and BindingDB, as well as known drug-target interactions from DrugBank have demonstrated the superior prediction performance of our method, and suggested that it can offer a useful tool for drug development and drug repositioning.

bioinformatics↗